These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30108065)

  • 1. Treatment of AL amyloidosis with bendamustine: a study of 122 patients.
    Milani P; Schönland S; Merlini G; Kimmich C; Foli A; Dittrich T; Basset M; Müller-Tidow C; Bochtler T; Palladini G; Hegenbart U
    Blood; 2018 Nov; 132(18):1988-1991. PubMed ID: 30108065
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to bendamustine is associated with a survival advantage in a heavily pretreated patients with AL amyloidosis.
    Milani P; Schönland S; Palladini G; Kimmich C; Basset M; Russo F; Foli A; Perlini S; Bochtler T; Ho AD; Merlini G; Hegenbart U
    Amyloid; 2017 Mar; 24(sup1):56-57. PubMed ID: 28434298
    [No Abstract]   [Full Text] [Related]  

  • 3. Bendamustine-Induced Nephrogenic Diabetes Insipidus in a Patient With AL Amyloidosis.
    Uwumugambi NA; Sanchorawala V; Shelton AC; Stern L; Gordon CE
    Am J Kidney Dis; 2017 Feb; 69(2):317-319. PubMed ID: 27780577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of IgM-associated immunoglobulin light-chain amyloidosis with rituximab-bendamustine.
    Manwani R; Sachchithanantham S; Mahmood S; Foard D; Sharpley F; Rezk T; Lane T; Quarta C; Fontana M; Lachmann HJ; Gillmore JD; Whelan C; Hawkins PN; Wechalekar AD
    Blood; 2018 Aug; 132(7):761-764. PubMed ID: 29925500
    [No Abstract]   [Full Text] [Related]  

  • 5. Updated analysis of phase 2 study of bendamustine and dexamethasone in patients with relapsed/refractory systemic light chain (AL) amyloidosis.
    Lentzsch S; Lagos GG; Comenzo RL; Zonder JA; Pregja S; Osman K; Tsai WY; Landau H; Sanchorawala V
    Amyloid; 2019; 26(sup1):113-114. PubMed ID: 31343313
    [No Abstract]   [Full Text] [Related]  

  • 6. Bendamustine therapy associated resolution of anemia and splenomegaly in myelofibrosis.
    Tefferi A; Cerquozzi S; Liaw J
    Am J Hematol; 2016 Feb; 91(2):E6-7. PubMed ID: 26587685
    [No Abstract]   [Full Text] [Related]  

  • 7. Bendamustine in relapsed/refractory multiple myeloma: the "real-life" side of the moon.
    Musto P; Fraticelli VL; Mansueto G; Madonna E; Nozza A; Andriani A; Mussetti A; Ballanti S; Bongarzoni V; Baraldi A; Patriarca F; Vincelli D; Falcone A; Derudas D; Califano C; Zambello R; Mele G; Fragasso A; Baldini L; Storti S
    Leuk Lymphoma; 2015 May; 56(5):1510-3. PubMed ID: 25651428
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of bendamustine in the management of plasma cell myeloma.
    Gertz MA
    Leuk Lymphoma; 2015 May; 56(5):1195-6. PubMed ID: 25347428
    [No Abstract]   [Full Text] [Related]  

  • 9. A good clonal response to chemotherapy in AL amyloidosis is associated with improved quality of life and function at 1 year.
    Carter JP; Foard D; Rannigan L; Aliaz K; Mahmood S; Sachchithanantham S; Fontana M; Quarta C; Martinez De Azcona Naharro A; Youngstein T; Rezk T; Wechalekar A; Whelan C; Lachmann H; Hawkins P; Gillmore J; Lane T
    Amyloid; 2017 Mar; 24(sup1):72-73. PubMed ID: 28434320
    [No Abstract]   [Full Text] [Related]  

  • 10. Reduced bendamustine for elderly patients with follicular lymphoma.
    Masamoto Y; Shimura A; Kurokawa M
    Ann Hematol; 2022 Mar; 101(3):713-715. PubMed ID: 34152427
    [No Abstract]   [Full Text] [Related]  

  • 11. Bendamustine conditioning for refractory type I cryoglobulinemia.
    Martin M; Lipsker D; Fornecker LM; Toussaint E; Martin T
    Joint Bone Spine; 2016 Oct; 83(5):591-2. PubMed ID: 26677988
    [No Abstract]   [Full Text] [Related]  

  • 12. Bendamustine-rituximab in mantle cell lymphoma.
    Lipsky A; Martin P
    Lancet Haematol; 2017 Jan; 4(1):e2-e3. PubMed ID: 27927585
    [No Abstract]   [Full Text] [Related]  

  • 13. Bendamustine can be a bridge to allogeneic transplantation in relapsed Hodgkin lymphoma refractory to brentuximab vedotin.
    Howell M; Gibb A; Radford J; Linton K
    Br J Haematol; 2017 Dec; 179(5):841-843. PubMed ID: 27447404
    [No Abstract]   [Full Text] [Related]  

  • 14. [Two cases of malignant lymphoma with reactivation of resolved hepatitis B virus infection after bendamustine hydrochloride monotherapy].
    Hiraki Y; Kawano A; Shigematsu H; Miki K; Nomura H; Shimoda S
    Nihon Shokakibyo Gakkai Zasshi; 2016 Sep; 113(9):1582-7. PubMed ID: 27593368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations on the clinical use of bendamustine in lymphoproliferative syndromes and multiple myeloma.
    Peñalver FJ; Delgado J; Loscertales J; Sastre JL; Peña A; Olave MT; Osorio S; de la Fuente A; Salar A; Grande C; Pérez Ceballos E; Debén G; Echeveste A; Casado F; de la Rubia J; Lahuerta JJ; Mateos MV
    Eur J Haematol; 2016 May; 96(5):532-40. PubMed ID: 26179864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage therapy with bendamustine for temozolomide refractory recurrent anaplastic gliomas: a prospective phase II trial.
    Chamberlain MC; Colman H; Kim BT; Raizer J
    J Neurooncol; 2017 Feb; 131(3):507-516. PubMed ID: 28204914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating the Hodgkin's Lymphoma Variant of Richter's Transformation.
    Zahid MF
    J Coll Physicians Surg Pak; 2016 Apr; 26(4):344-5. PubMed ID: 27097715
    [No Abstract]   [Full Text] [Related]  

  • 18. Bendamustine for the treatment of multiple myeloma in first-line and relapsed-refractory settings: a review of clinical trial data.
    Palumbo A; Offidani M; Patriarca F; Petrucci MT; Cavo M
    Leuk Lymphoma; 2015 Mar; 56(3):559-67. PubMed ID: 24884319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bendamustine: role and evidence in lymphoma therapy, an overview.
    Derenzini E; Zinzani PL; Cheson BD
    Leuk Lymphoma; 2014 Jul; 55(7):1471-8. PubMed ID: 24180334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bendamustine reactivates latent Epstein-Barr virus.
    Fernandez SG; Miranda JJ
    Leuk Lymphoma; 2016 May; 57(5):1208-10. PubMed ID: 26371746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.